| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Cohen Cheryl serves as a Director at IBRX and has filed Form 4s across 3 companies. Across recent SEC filings that breaks down to 1 buy and 8 sells. Those positions are worth an estimated $1.1M at current prices.
Historically, Cohen Cheryl's trades have earned a strong insider score of 77/100 across 4 rated trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +58.8%.
The biggest single holding is IBRX (~$1.1M) as Director. The recent filings there lean toward selling, a net 312,574 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 2, 2026 | IBRX Immunitybio, Inc. | Director | Sale+OE10b5-1 | 81,056 | $10.50 | $851,088.00 | -44.7% | - | - | |
| Jul 2, 2026 | IBRX Immunitybio, Inc. | Director | Sale+OE10b5-1 | 131,210 | $9.50 | $1,246,941.11 | -51.1% | 0.0% | - | |
| Aug 23, 2021 | IBRX Immunitybio, Inc. | Director | Sell | 24,777 | $10.07 | $249,602.89 | -11.0% | -43.9% | -64.1% | |
| Aug 18, 2021 | IBRX Immunitybio, Inc. | Director | Sell | 45,531 | $10.12 | $460,750.44 | -16.8% | -24.4% | -53.6% | |
| Aug 11, 2020 | IBRX Immunitybio, Inc. | Director | Sell | 30,000 | $9.96 | $298,785.00 | -10.0% | - | - | |
| Sep 12, 2018 | IMUX Immunic, Inc. | Director | Sell | 3,500 | $0.55 | $1,925.00 | -100% | - | - | |
| Oct 26, 2015 | IMUX Immunic, Inc. | Director | Buy | 3,500 | $7.17 | $25,089.75 | New | - | - |